Atul Gawande takes aim at surging prescription drug costs as chief of cryptic Buffett-Bezos-Dimon venture now christened 'Haven'
Early last year, when the powerful trio of Warren Buffett (Berkshire Hathaway), Jamie Dimon (JPMorgan Chase) and Jeff Bezos (Amazon) joined forces to fix the “broken” US healthcare system, the industry shuddered with a mixture of fear and anticipation. Months later, well regarded Indian-American doctor, author and renaissance man Atul Gawande entered the fold as the venture’s chief — but details on how the entity intended to reach its goal remained scant. On Wednesday, the non-profit venture was officially christened “Haven,” and its plans to disrupt the status quo were fleshed out, albeit minimally.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.